review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12026-007-0043-X |
P698 | PubMed publication ID | 17989941 |
P50 | author | Barry E Storer | Q75025396 |
Paul J Martin | Q85264853 | ||
P2093 | author name string | Effie W Petersdorf | |
John A Hansen | |||
Steven Wang | |||
Ming-Tseh Lin | |||
Jason W Chien | |||
P2860 | cites work | Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants | Q73942359 |
Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q74481774 | ||
Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology | Q77371989 | ||
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation | Q77374839 | ||
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient | Q77531717 | ||
Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants | Q77531846 | ||
Variable airway responsiveness to inhaled lipopolysaccharide | Q77950281 | ||
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation | Q78102353 | ||
A New Leukocyte Isoantigen System in Man | Q78303530 | ||
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q78778794 | ||
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation | Q80001093 | ||
Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation | Q81398889 | ||
IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation | Q81820225 | ||
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 | ||
Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle | Q93753157 | ||
House dust endotoxin and wheeze in the first year of life | Q23915493 | ||
Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors | Q33569352 | ||
LEUKOCYTE GROUPING. A METHOD AND ITS APPLICATION | Q33949049 | ||
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors | Q34128401 | ||
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation | Q34186689 | ||
Hu-1: Major Histocompatibility Locus in Man | Q34221435 | ||
Minor histocompatibility antigens. | Q34231514 | ||
LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO. | Q34256002 | ||
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation | Q34582448 | ||
Bone-marrow transplantation (first of two parts). | Q34649003 | ||
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program | Q34730308 | ||
Emerging trends in the search for genetic variants predisposing to human obesity | Q35154206 | ||
Cytokine dysregulation and acute graft-versus-host disease | Q35607602 | ||
The role of cytokines in graft-versus-host reactions and disease | Q35781650 | ||
Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor | Q35847781 | ||
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets | Q35847952 | ||
Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation | Q35849483 | ||
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. | Q36363380 | ||
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice | Q37387820 | ||
Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. | Q37388260 | ||
Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. | Q37546013 | ||
The National Marrow Donor Program: how it works, accomplishments to date | Q38788625 | ||
Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor | Q39067202 | ||
Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor | Q39124249 | ||
Reconstitution in Severe Combined Immunodeficiency by Transplantation of Marrow from an Unrelated Donor | Q39169795 | ||
Significance of HLA and non-HLA antigens in bone marrow transplantation | Q39186920 | ||
Marrow transplantation from donors other than HLA-identical siblings | Q39278390 | ||
Treatment of severe combined immunodeficiency with bone-marrow from an unrelated, mixed-leucocyte-culture-non-reactive donor | Q39342891 | ||
Human mixed-lymphocyte culture reaction: genetics, specificity, and biological implications | Q39410713 | ||
Human marrow transplantation: an immunological perspective | Q39462944 | ||
1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
Metropolitan home living conditions associated with indoor endotoxin levels | Q39566659 | ||
Cellular immunology and the pathogenesis of graft versus host reactions | Q39874099 | ||
Cell-mediated cytotoxicity, allograft rejection, and tumor immunity | Q39874128 | ||
The inheritance of leukocyte antigens. | Q39964736 | ||
Chronic obstructive airways disease after bone marrow transplantation | Q40184865 | ||
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 | ||
Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation | Q40689796 | ||
Cytokine cascades in acute graft-versus-host disease | Q41592255 | ||
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease | Q41640832 | ||
Marrow transplantation from related donors other than HLA-identical siblings | Q43519981 | ||
Duration of immunosuppressive treatment for chronic graft-versus-host disease | Q43590716 | ||
Bronchiolitis obliterans complicating bone marrow transplantation | Q43686789 | ||
Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. | Q43702800 | ||
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation | Q43727815 | ||
Pets and vermin are associated with high endotoxin levels in house dust | Q43817860 | ||
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program | Q44216272 | ||
IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. | Q44440386 | ||
Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation | Q44444274 | ||
Use and abuse of hemopoietic cell grafts in immune deficiency diseases. | Q44580382 | ||
Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor | Q44613351 | ||
Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation | Q44746212 | ||
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma | Q44905104 | ||
The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation | Q45420884 | ||
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome | Q47359749 | ||
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. | Q47762458 | ||
Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. | Q51681296 | ||
Cellular immunology in a historical perspective. | Q51843846 | ||
Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. | Q52059946 | ||
Late pulmonary impairment following allogeneic bone marrow transplantation. | Q53006821 | ||
Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs. | Q53978378 | ||
Aplastic anaemia treated by marrow transplantation. | Q54533211 | ||
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism | Q57918712 | ||
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation | Q58814344 | ||
Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation | Q58814550 | ||
Microdroplet Assay of Human Serum Cytotoxins | Q59059757 | ||
Release and Activity of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease | Q61496390 | ||
Immunologic reconstitution in severe combined immunodeficiency following transplantation with parental bone marrow | Q67488481 | ||
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate | Q67903584 | ||
A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation | Q67966340 | ||
Probability of finding HLA-matched unrelated marrow donors | Q68133073 | ||
Risk factors for airflow obstruction in recipients of bone marrow transplants | Q68193104 | ||
Graft-versus-host disease | Q68195420 | ||
Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies | Q68196174 | ||
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation | Q68809214 | ||
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma | Q69482387 | ||
Bone-marrow transplantation from an HL-A non-identical but mixed-lymphocyte-culture identical donor | Q69998321 | ||
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
Immunological reconstitution of sex-linked lymphopenic immunological deficiency | Q70099373 | ||
Marrow transplantation from donors other than HLA identical siblings | Q70176462 | ||
Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease | Q70178713 | ||
Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease | Q70336991 | ||
Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus | Q70523739 | ||
Development of registries of HLA-typed volunteer marrow donors | Q71547094 | ||
The spectrum of bronchiolitis obliterans | Q71652665 | ||
Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation | Q71793218 | ||
Severity of asthma is related to endotoxin in house dust | Q71906927 | ||
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of | Q71911659 | ||
Transplantation of marrow from an unrelated donor to a patient with acute leukemia | Q72145731 | ||
Bone Marrow Donors Worldwide: a successful exercise in international cooperation | Q72781355 | ||
Compartmentalization of the inflammatory response to inhaled grain dust | Q73047157 | ||
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors | Q73126126 | ||
Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants | Q73205710 | ||
Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation | Q73832263 | ||
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome | Q73934563 | ||
P433 | issue | 1 | |
P304 | page(s) | 56-78 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Immunologic Research | Q15754981 |
P1476 | title | Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes | |
P478 | volume | 41 |
Q26750999 | Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets |
Q48236316 | Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL. |
Q56898457 | Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT |
Q37262519 | Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality |
Q33558113 | Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation |
Q33455711 | HLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies in 6384 umbilical cord blood units and transplantation matching and engraftment statistics in the Zhejiang cord blood bank of China |
Q35223947 | NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges |
Q26765845 | NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment |
Q56897193 | Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients |
Q37678207 | Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation |
Q33452455 | The impact of immunogenetics and clinical factors on the outcome of unrelated cord blood transplantation: the Milano Cord Blood Bank data |
Q41218452 | The role of bacteria and pattern recognition receptors in GVHD |
Q36444328 | Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy. |
Q35998361 | What Next? The Next Transit from Biology to Diagnostics: Next Generation Sequencing for Immunogenetics |
Search more.